Benefits
Weight management
Pooled analyses of randomized trials found chitosan users lost about 0.9 to 1.7 kg more than placebo, mostly over a few months. Many trials were of poor quality, and those that were larger, longer or better concealed showed much smaller losses; reviewers judged the effect in high-quality trials minimal and unlikely to be clinically meaningful. No trial has tested ChitoClear itself.
Fat binding in the gut
Chitosan's positive charge lets it bind negatively charged fats and bile acids, which is the proposed basis for its use. In the trials pooled by a 15-trial review, however, chitosan did not clearly increase the amount of fat excreted in stool compared with placebo.
Cholesterol support
In a pooled analysis of six placebo-controlled trials in 416 people with high cholesterol, chitosan lowered total cholesterol by about 11.6 mg/dL but did not significantly change LDL, HDL or triglycerides. A review of 15 weight-loss trials also found a small total cholesterol drop of about 0.2 mmol/L, which was smaller in the better-designed trials.
Mechanism of action
Electrostatic fat binding
Positively charged chitosan binds negatively charged fatty acids and bile acids in the gut, forming complexes that are excreted rather than absorbed.
Bile-acid sequestration
Removing bile acids prompts the body to use cholesterol to make more, supporting lower circulating cholesterol.
Clinical trials
Systematic review and meta-analysis of 15 randomized controlled trials with 18 treatment arms (Huang et al. 2020, Crit Rev Food Sci Nutr)
1,130 adults across 15 trials.
Body weight fell about 0.89 kg more than control (95% CI 0.38 to 1.41), BMI 0.39 kg/m2 and body fat 0.69 percentage points. Effects were seen mainly at doses above 2.4 g/day, in trials shorter than 12 weeks and in people with overweight or obesity. The authors called chitosan a possible adjunctive tool and asked for better trials.
Systematic review and meta-analysis of 15 randomized controlled trials lasting at least 4 weeks (Jull et al. 2008, Cochrane Database Syst Rev)
1,219 adults with overweight or obesity.
Chitosan produced 1.7 kg more weight loss than placebo (95% CI 1.3 to 2.1) and a 0.2 mmol/L drop in total cholesterol, but trials with adequate allocation concealment, larger size or longer duration showed substantially smaller effects. The authors concluded that in high-quality trials the effect on body weight is minimal and unlikely to be clinically significant. Faecal fat excretion and adverse events did not clearly differ from placebo.
Meta-analysis of 6 randomized, placebo-controlled trials (Baker et al. 2009, Ann Nutr Metab)
416 people with high cholesterol.
Chitosan lowered total cholesterol by 11.59 mg/dL (95% CI 1.73 to 21.45) but did not significantly change LDL cholesterol, HDL cholesterol or triglycerides.